For Quick Alerts
For Daily Alerts

Natco Pharma - Board Meeting on May 22, 2015

By Religare

With reference to the SEBI Circular dated May 11, 2015, Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2015 inter alia, will consider the following:

1. Formulation of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive information pursuant to Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and

2. Code of Conduct to regulate, monitor and report trading by Insiders pursuant to Regulation 9 of the said Regulations.

Story first published: Tuesday, May 19, 2015, 12:20 [IST]
Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more